Jiapeng Lenny Li

Jiapeng Lenny Li is a Senior Investment Director at Sinovation Ventures since July 2020, specializing in growth investments within the healthcare and consumer sectors. Significant portfolio involvement includes Meditrust, Glinx, Kilala, Ruishi, Wallaby/Phenox, and ET Healthcare/Gator. Prior to Sinovation Ventures, Jiapeng held the position of Senior Associate at YunFeng Capital, focusing on healthcare investments, and worked as an Investment Banking Analyst at UBS in the Asia Healthcare Group. Jiapeng also co-founded KanDongSee and served as Head of Marketing. Academic qualifications include a Bachelor's Degree in Mathematics and Statistics from the University of Oxford, a Master's Degree in Operational Research from Columbia University, and part-time studies in Medical Science at The University of Hong Kong.